NCT00458419View on ClinicalTrials.gov

Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

May 31, 2007

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

naloxone versus placebo

10 mg of naloxone administered IV or normal saline administered IV in randomized order at different visits

DRUG

intravenous injection of normal saline or naloxone

Arm A: 10 mg of naloxone given IV in 25 ml of normal saline Arm B: 25 ml of normal saline

Trial Locations (1)

03756-0001

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00458419 - Role of Endorphins in the Perception of Dyspnea in Patients With Chronic Obstructive Pulmonary Disease | Biotech Hunter | Biotech Hunter